Table 4 Distribution of prescribed anti-infectives; by groups, subgroups and ATC codes; in a Teaching and a Non-teaching hospital in Ujjain district, India
Antibiotics groups/subgroups with ATC codes | Teaching hospital | Non-teaching hospital | |
|---|---|---|---|
| Â | Â | n (%) | n (%) |
Total prescribing occasions | Â | 30311 (100) | 35534 (100) |
ANTIBACTERIALS FOR SYSTEMIC USE; J01 | Â | 25867 (85.3) | 35427 (99.7) |
Tetracyclines; J01A | Tetracyclines; J01AA | 2235 (7.4) | 94 (0.2) |
Amphenicols; J01B | Amphenicols; J01BA | 40 (0.1) | 0 (0.0) |
ÎČ- lactam antibiotics, penicillin; J01C | Â | 3100 (10.2) | 3268 (9.8) |
| Â | Penicillins with extended spectrum; J01CA | 778 (2.6) | 808 (2.3) |
| Â | Beta-lactamase sensitive penicillins; J01CE | 3 (0.0) | 18 (0.0) |
| Â | Beta-lactamase inhibitors; J01CG | 5 (0.0) | 2 (0.0) |
| Â | Combination of penicillin including beta lactamase antibiotics; J01CR | 2314 (7.6) | 2440 (7.4) |
Other beta lactam; J01D | Â | 4333 (14.3) | 11929 (33.3) |
| Â | 1st generation Cephalosporins; J01DB | 645 (2.1) | 135 (0.4) |
| Â | 2nd generation Cephalosporins; J01DC | 2 (0.0) | 516 (1.4) |
| Â | 3rd generation Cephalosporins; J01DD | 3686 (12.2) | 11174 (31.3) |
| Â | Fourth-generation Cephalosporins; J01DE | 0 (0.0) | 51 (0.1) |
| Â | Carbapenems J01DH | 0 (0.0) | 53 (0.1) |
Sulfonamide with Trimethoprim; J01E | Combination of Sulfonamide with Trimethoprim; J01EE | 928 (3.1) | 6 (0.01) |
Macrolides, lincosamides; J01F | Â | 842 (2.8) | 150 (0.6) |
| Â | Macrolides; J01FA | 58 (0.2) | 78 (0.3) |
| Â | Lincosamides; J01FF | 784 (2.6) | 72 (0.3) |
Aminoglycoside; J01G | Â | 4068 (13.4) | 3484 (10.2) |
| Â | Streptomycin; J01GA | 212 (0.7) | 4 (0.0) |
| Â | Other Aminogylcosides; J01GB | 3856 (12.7) | 3480 (10.2) |
Quinolones; J01M | Fluoroquinolones; J01MA | 6887 (22.7) | 4156 (11.7) |
Combination of antibiotics; *J01R | Combination of Antibiotics; *J01RA | 1194 (3.9) | 9084 (25.1) |
Other antibiotics; J01X | Â | 2240 (7.4) | 3256 (8.8) |
| Â | Glycopeptide antibacterials; J01XA | 6 (0.0) | 16 (0.0) |
| Â | Imidazole derivatives; J01XD | 2216 (7.3) | 3173 (8.6) |
| Â | Nitrofurantoin; J01XE | 18 (0.1) | 5 (0.0) |
| Â | Other antibacterials; J01XX | 0 (0.0) | 62 (0.2) |
DRUGS FOR TREATMENT OF TUBERCULOSIS; J04 | Â | 2257 (7.5) | 7 (0.02) |
Drugs for treatment of Tuberculosis; J04A | Â | Â | Â |
| Â | Antibiotics; J04AB | 574 (1.9) | 7 (0.02) |
| Â | Hydrazides; J04AC | 570 (1.9) | 0 (0.0) |
| Â | Other drugs for treatment of tuberculosis; J04AK | 1113 (3.7) | 0 (0.0) |
AGENTS AGAINST AMOEBIASIS & OTHER PROTOZOAL DISEASES P01; | Â | 2187 (7.2) | 100 (0.3) |
Agents against amoebiasis & protozoal diseases; P01A | Â | Â | Â |
| Â | Nitroimidazole derivatives; P01AB | 2187 (7.2) | 95 (0.3) |
| Â | Other agents against amoebiasis & other protozoal diseases; P01AX | 0 (0.0) | 5 (0.01) |